GB Sciences Obtains Exclusive License for Patented Oral Thin Film Technology Containing Cannabis and Hemp-Derived Ingredients
June 13, 2019
At GB Sciences, we have two equally important constituencies–the patients who need what we do, and the investors that support what we do. Without the latter, we could not help the former.
Our growth strategy is two-pronged — while we continue to explore the leading edge of biomedical research for the development of cannabis-based therapies, we also take advantage of the recreational market for cannabis in Nevada.
The sale of our product from our Las Vegas cultivation facility supports the research that we do. We encourage investors to read our press releases and public filings. Questions can be emailed to our Director of Public Information, Liz Bianco, at liz@gbsciences.com – and welcome aboard!
